Use of medicines recommended for secondary prevention of acute coronary syndrome

Authors

  • Mari Ângela Gaedke Universidade de Santa Cruz do Sul; Departamento de Enfermagem e Odontologia
  • Juvenal Soares Dias da Costa Universidade do Vale do Rio dos Sinos
  • Euler Roberto Fernandes Manenti Hospital Mãe de Deus; Instituto de Medicina Vascular
  • Ruth Liane Henn Universidade do Vale do Rio dos Sinos
  • Vera Maria Vieira Paniz Universidade do Vale do Rio dos Sinos
  • Marcelo Felipe Nunes Universidade do Vale do Rio dos Sinos
  • Monique Adriane da Motta Universidade do Vale do Rio dos Sinos
  • Maria Teresa Anselmo Olinto Universidade Federal de Ciências da Saúde de Porto Alegre; Departamento de Nutrição

DOI:

https://doi.org/10.1590/S0034-8910.2015049005978

Keywords:

Acute Coronary Syndrome, Secondary Prevention, Medication Adherence, Evidence-Based Medicine, Cohort Studies

Abstract

ABSTRACT OBJECTIVE : To analyze if the demographic and socioeconomic variables, as well as percutaneous coronary intervention are associated with the use of medicines for secondary prevention of acute coronary syndrome. METHODS : In this cohort study, we included 138 patients with acute coronary syndrome, aged 30 years or more and of both sexes. The data were collected at the time of hospital discharge, and after six and twelve months. The outcome of the study was the simultaneous use of medicines recommended for secondary prevention of acute coronary syndrome: platelet antiaggregant, beta-blockers, statins and angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker. The independent variables were: sex, age, education in years of attending, monthly income in tertiles and percutaneous coronary intervention. We described the prevalence of use of each group of medicines with their 95% confidence intervals, as well as the simultaneous use of the four medicines, in all analyzed periods. In the crude analysis, we verified the outcome with the independent variables for each period through the Chi-square test. The adjusted analysis was carried out using Poisson Regression. RESULTS : More than a third of patients (36.2%; 95%CI 28.2;44.3) had the four medicines prescribed at the same time, at the moment of discharge. We did not observe any differences in the prevalence of use in comparison with the two follow-up periods. The most prescribed class of medicines during discharge was platelet antiaggregant (91.3%). In the crude analysis, the demographic and socioeconomic variables were not associated to the outcome in any of the three periods. CONCLUSIONS : The prevalence of simultaneous use of medicines at discharge and in the follow-ups pointed to the under-utilization of this therapy in clinical practice. Intervention strategies are needed to improve the quality of care given to patients that extend beyond the hospital discharge, a critical point of transition in care.

Published

2015-01-01

Issue

Section

Original Articles

How to Cite

Gaedke, M. Ângela, Costa, J. S. D. da, Manenti, E. R. F., Henn, R. L., Paniz, V. M. V., Nunes, M. F., Motta, M. A. da, & Olinto, M. T. A. (2015). Use of medicines recommended for secondary prevention of acute coronary syndrome. Revista De Saúde Pública, 49, 88. https://doi.org/10.1590/S0034-8910.2015049005978